Buy Marico Ltd For Target Rs. 500 - ICICI Securities
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2021/05/92abad2a4af2b8d3ce451fbd7062915b.jpg)
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Penetration-driven growth and market share gains are DCF-accretive; BUY
4Q volumes grew 25% (~20% adjusting for base) - an outperformance. Significant market share gains and sustained growth momentum in near-total portfolio is pleasing. We like its strategy of prioritising market share / volume growth over margins. In India, a “growth market”, investors tend to (rightly) ignore short-term profit sacrifice, provided the trajectory of volume outperformance is clear (as it’s DCF-accretive).
Also, we like the distribution expansion plans in both urban (chemist channel) and rural (indirect to direct conversion and expanding footprint by another 25%). New launches in (healthy) foods portfolio is likely to provide another leg to growth (targeting ~Rs4.5-5bn revenue in FY22 and ~Rs8.5-10bn in FY24 (target of ~Rs3bn in FY21 achieved)). A resilient international portfolio adds to potential outperformance in India. We stay believers. Our stock rating moves up a notch to BUY (from ADD); revised target price of Rs500.
* Broad-based revenue growth: Consolidated revenue / EBITDA / recurring PAT grew 34% / 13% / 17%. Domestic revenue grew 37% driven by 25% volume growth (2-year CAGR of 10%; management said adjusting for the lower base volume growth was ~18-20%) with continued improving consumer sentiment. This performance was led by strong GT performance in rural (+42% volume growth) growing 1.8x of urban (+23% volume growth). E-commerce grew by 81% (contributes to ~8% of business) while Modern Trade declined (-17% YoY) due to higher base driven by pantry stocking in Mar’20. CSD also grew by 59% on a lower base.
* Segment performance: Parachute revenue grew 38% with 29% volume growth driven by market share gains as it partially absorbed input cost inflation. Value added hair oils (VAHO) continued its third consecutive quarter of volume growth (+22% volume and value both). Saffola edible oils continued its strong performance (+17% volume, +43% value) on a high base, benefitting from increased penetration. In other categories, healthy foods grew 134% (oats grew ~84%) while Premium personal care segment witnessed sequential recovery with modest volume decline. Saffola Honey is also performing well with ~double-digit market shares in MT and ~25% market share in e-commerce where the category is over-indexed.
* International business: Revenue grew 23% in constant currency terms (+25% reported) driven by broad-based performance across geographies - Bangladesh (+20% in CC) and continued performance in South Africa (+48% in CC), South East Asia (+13% in CC), MENA (+62% in CC).
To Read Complete Report & Disclaimer Click Here
For More ICICI Securities Disclaimer https://www.icicisecurities.com/AboutUs.aspx?About=7
Above views are of the author and not of the website kindly read disclaimer
![](https://portfolio.investmentguruindia.com/uploads/news/insurance 123.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Axis Securities Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Wipro.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/2b1715f7e03b51b0ac9c014eb224fc1f.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/gdp22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Geojit Financial Services.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Dollar retures 2.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/health22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Arvind Kapil, MD and CEO, Poonawalla Fincorp.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/stock8.jpg)